Related references
Note: Only part of the references are listed.Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial
Robert Stoehr et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
Geoffrey A. Block et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study
Ehimare Akhabue et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Klotho, fibroblast growth factor-23, and the renin-angiotensin system an analysis from the PEACE trial
Brian A. Bergmark et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
Ineke Boeckmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
Giuseppe Vergaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
Jozine M. ter Maaten et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
Alexander Grabner et al.
SCIENTIFIC REPORTS (2017)
Evaluation of a New Fully Automated Assay for Plasma Intact FGF23
Jean-Claude Souberbielle et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
Huixin Hao et al.
ONCOTARGET (2016)
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Sharon M. Moe et al.
CIRCULATION (2015)
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Societa Italiana di Biochimica Clinica (SIBIOC)
Antonio Fortunato et al.
CLINICA CHIMICA ACTA (2015)
FGF23 is associated with disease severity and prognosis in chronic heart failure
Gerhard Poelzl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
New Insights Into the FGF23-Klotho Axis
Hannes Olauson et al.
SEMINARS IN NEPHROLOGY (2014)
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
Marc G. Vervloet et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
FGF23: A Mature Renal and Cardiovascular Risk Factor?
Carmine Zoccali et al.
BLOOD PURIFICATION (2013)
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
Justin Silver et al.
NATURE REVIEWS NEPHROLOGY (2013)
Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
Sarah N. Cilvik et al.
PLOS ONE (2013)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
C-terminal FGF23 is a strong predictor of survival in systolic heart failure
Damien Gruson et al.
PEPTIDES (2012)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
Martin H. de Borst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP
Concetta Prontera et al.
CLINICA CHIMICA ACTA (2009)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Direct renin assay and plasma renin activity assay compared
D Hartman et al.
CLINICAL CHEMISTRY (2004)
Share Paper
